Global Bioburden Testing Market Analysis, Drivers, Restraints, Opportunities, Threats, Trends, Applications, and Growth Forecast to 2027
The Bioburden Testing Market report overview:
“The global Bioburden Testing Market size is expected to be worth around US$ xx Billion by 2021 from US$ X.xx million in 2031, growing at a CAGR of X.x% during the forecast period 2021 to 2031.”
The Bioburden Testing Market report also offers insightful and detailed information regarding the various key players operating in the global bioburden testing market, and their financials, apart from strategies, acquisitions & mergers, and market footprint. The global bioburden testing market is being segmented on the basis of test type, product type, application, end-user, and region.
Bioburden is normally defined as the number of bacteria living on a surface such as that of medical instruments or equipment etc. that has not been sterilized. The term is most often used in the context of bioburden testing, which is also known as microbial limit testing and is performed on pharmaceutical and medical products for quality control purposes.
Products or components used in the pharmaceutical or medical field require control of microbial levels during processing and handling. Bioburden or microbial limit testing on these products proves that these requirements have been met.
The US FDA sets the regulatory standards in the US for bioburden testing; whereas, ISO (International Organization for Standardization) maintains the global standards for regulations.
Rapid and exponential growth in the medical device industry has been accelerating the use of bioburden testing and is a primary driver for the growth of the global bioburden testing market. increasing food safety standards is another important factor driving the growth of the global bioburden testing market.
Rising investments by companies on R&D in lifesciences and increasing product recalls due to microbial contamination are other factors driving growth of the target market in the recent past.
Some major factors restraining growth of the global bioburden testing market include time-consuming approval processes for new drugs. High cost for bioburden testing is expected to act as a restrain to growth of markets in developing and underdeveloped countries. Lack of trained professionals to conduct testing in these countries is another major factor supporting this restraint.
The market in the US accounts for major revenue contribution to the bioburden testing market in North America, and is expected to continue its dominance over the forecast period.
Revenue from the market in Asia Pacific is projected to increase at the highest CAGR during the forecast period due to various factors such as growing medical devices industry, robust investments in the healthcare sector, and rapidly increasing growth in pharmaceutical and biotechnology industries, growing number of government initiatives, and rising awareness about bioburden testing in various Asian countries.
Global Bioburden Testing Market Segmentation:
Segmentation on basis of test type:
- Aerobic count
- Anaerobic count
- Fungi/mold count
- Spores count
Segmentation on basis of product type:
- Culture media and reagents kits
- Other consumables
- Automated microbial identification systems
- Polymerase chain reaction (pcr)
- Other instruments
Segmentation on basis of application:
- Raw material testing
- Medical devices testing
- In-process testing
- Sterilization validation testing
- Equipment cleaning validation
Segmentation on basis of end-user:
- Pharmaceutical and biotechnology companies
- Medical device manufacturers
- Contract manufacturing organizations (CMOS)
- Manufacturers of food & beverage and agricultural products
- Microbial testing laboratories
Segmentation on basis of Region:
- North America
- Asia Pacific
- Latin America
- Middle East & Africa.
Attribute Report Details Market Size Ask For Market Size Growth Rate Ask For Growth Rate Key Companies Ask For Companies Report Coverage Revenue analysis, Competitive landscape, Key company analysis, Market Trends, Key segments, Distribution Channel, Market Dynamics, COVID-19 Impact Analysis and more… Historical Data Period 2015-2020 Base Year 2022 Forecast Period 2022-2031 Region Scope North America, Europe, Asia-Pacific, South America, Middle East & Africa Country Scope United States, Canada and Mexico, Germany, France, UK, Russia and Italy, China, Japan, Korea, India and Southeast Asia, Brazil, Argentina, Colombia etc.Saudi Arabia, UAE, Egypt, Nigeria and South Africa Revenue in US$ Mn
- Charles River Laboratories International, Inc.
- Sigma-Aldrich Corporation
- SGS S.A.
- WuXi PharmaTech (Cayman) Inc.
- Merck & Co., Inc.
- Becton, Dickinson and Company
- North American Science Associates
- ATS Labs, Inc.
- Nelson Laboratories
- Pacific Biolabs
Request for TOC
Why Choose Us
- 360 Degree Approach
- Growth Consulting
- 24/7 Research Support
- Comprehensive-Level of Customization
- Comprehensive-Level of Customization
- Competitive Intelligence
- Single-Country/ Region Intelligence
- Post-Sale Service Assistance
- Access to Lead Analysts
- Available in PDF, Excel, Word/ PPT
Request for Customization
Don't just take our word. We are trusted by these great companies!